Eldon Smith - Net Worth and Insider Trading
Eldon Smith Net Worth
The estimated net worth of Eldon Smith is at least $12,800 dollars as of 2024-09-23. Eldon Smith is the Director of Cardiol Therapeutics Inc and owns about 4,000 shares of Cardiol Therapeutics Inc (TSX:CRDL) stock worth over $12,800. Details can be seen in Eldon Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eldon Smith has not made any transactions after 2019-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eldon Smith
Eldon Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eldon Smith owns 1 companies in total, including Cardiol Therapeutics Inc (TSX:CRDL) .
Click here to see the complete history of Eldon Smith’s form 4 insider trades.
Insider Ownership Summary of Eldon Smith
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-15 | Director |
Eldon Smith Latest Holdings Summary
Eldon Smith currently owns a total of 1 stock. Eldon Smith owns 4,000 shares of Cardiol Therapeutics Inc (TSX:CRDL) as of October 15, 2019, with a value of $12,800.
Latest Holdings of Eldon Smith
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-15 | 4,000 | 3.20 | 12,800 |
Holding Weightings of Eldon Smith
Eldon Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Eldon Smith has made a total of 1 transactions in Cardiol Therapeutics Inc (TSX:CRDL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cardiol Therapeutics Inc is the acquisition of 4,000 shares on October 15, 2019, which cost Eldon Smith around $10,840.
Insider Trading History of Eldon Smith
- 1
Eldon Smith Trading Performance
GuruFocus tracks the stock performance after each of Eldon Smith's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eldon Smith is 47.26%. GuruFocus also compares Eldon Smith's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eldon Smith within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eldon Smith's insider trading performs compared to the benchmark.
Performance of Eldon Smith
Eldon Smith Ownership Network
Eldon Smith Owned Company Details
What does Cardiol Therapeutics Inc do?
Who are the key executives at Cardiol Therapeutics Inc?
Eldon Smith is the Director of Cardiol Therapeutics Inc. Other key executives at Cardiol Therapeutics Inc include Senior Officer Guillermo Torre , Director & Senior Officer David Elsley , and Director & Senior Officer Christopher James Waddick .
Cardiol Therapeutics Inc (TSX:CRDL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cardiol Therapeutics Inc (TSX:CRDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiol Therapeutics Inc Insider Transactions
Eldon Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Eldon Smith. Currently GuruFocus does not have mailing address information for Eldon Smith.